Vitae Pharmaceuticals, Inc 4
4 · Vitae Pharmaceuticals, Inc · Filed Oct 25, 2016
Insider Transaction Report
Form 4
Applebaum Scott
General Counsel
Transactions
- Disposition to Issuer
Employee Stock Option (Right to Buy)
2016-10-25$12.25/sh−150,000$1,837,500→ 0 totalExercise: $8.75Exp: 2026-08-09→ Common Stock (150,000 underlying)
Footnotes (2)
- [F1]Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated September 13, 2016, by and among the Issuer, Allergan Holdco US, Inc. and Augusta Merger Sub, Inc., each outstanding option to purchase shares of the Issuer's common stock, whether or not exercisable or vested, was cancelled and the holder thereof became entitled to receive an amount in cash determined by multiplying (A) the excess, if any, of $21.00 over the exercise price per share of the common stock underlying such stock option by (B) the number of shares of common stock subject to such stock option.
- [F2]This option, which provided for vesting with respect to 1/4 of the shares of stock which are subject to this option on August 10, 2017 (the "Initial Vesting Date") and 1/48th of the shares of stock which are subject to this option monthly following the Initial Vesting Date, was cancelled and the Reporting Person became entitled to receive an amount in cash per the terms of the Merger Agreement, as described in footnote (1) above.